Henning Lauterbach

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Journal for immunotherapy of cancer

Vaccines

NPJ vaccines

Nature communications

Hookipa Pharma

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hookipa Pharma Apr 01 2019

Austria

Executive Director :: Preclinical R&D

Bavarian Nordic GmbH May 14 2007 - Mar 31 2019

Germany

Manager :: Immunology Research

Publications

Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Bhawna Sharma, Elena Bekerman, Hoa Truong, Johnny Lee, Maria Gamez-Guerrero, Archana Boopathy, Rohit Mital, Katell Bidet Huang, Sarah Ahmadi-Erber, Raphaela Wimmer, Sophie Schulha, Henning Lauterbach, Klaus Orlinger, Silpa Suthram, Mark G Lewis, Wade Blair, Azure Tariro Makadzange, Romas Geleziunas, Jeffrey P Murry, Sarah Schmidt
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates. Vaccines 12 (7) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Bhawna Sharma, Elena Bekerman, Hoa Truong, Johnny Lee, Maria Gamez-Guerrero, Archana Boopathy, Rohit Mital, Katell Bidet Huang, Sarah Ahmadi-Erber, Raphaela Wimmer, Sophie Schulha, Henning Lauterbach, Klaus Orlinger, Silpa Suthram, Mark G Lewis, Wade Blair, Azure Tariro Makadzange, Romas Geleziunas, Jeffrey P Murry, Sarah Schmidt
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates. Vaccines 12 (7) (2024)
Bhawna Sharma, Elena Bekerman, Hoa Truong, Johnny Lee, Maria Gamez-Guerrero, Archana Boopathy, Rohit Mital, Katell Bidet Huang, Sarah Ahmadi-Erber, Raphaela Wimmer, Sophie Schulha, Henning Lauterbach, Klaus Orlinger, Silpa Suthram, Mark G Lewis, Wade Blair, Azure Tariro Makadzange, Romas Geleziunas, Jeffrey P Murry, Sarah Schmidt
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates. Vaccines 12 (7) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer, Mohamed Habbeddine, Sandra Rosskopf, Judith Strauß, Valentin Just, Sarah Schmidt, Katell Bidet Huang, Felix Stemeseder, Timo Schippers, Ethan Stewart, Jakub Jez, Pedro Berraondo, Klaus K Orlinger, Henning Lauterbach
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment. Journal for immunotherapy of cancer 12 (4) (2024)
Archana Vidya Boopathy, Bhawna Sharma, Anurag Nekkalapudi, Raphaela Wimmer, Maria Gamez-Guerrero, Silpa Suthram, Hoa Truong, Johnny Lee, Jiani Li, Ross Martin, Wade Blair, Romas Geleziunas, Klaus Orlinger, Sarah Ahmadi-Erber, Henning Lauterbach, Tariro Makadzange, Brie Falkard, Sarah Schmidt
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys. NPJ vaccines 8 (1) (2023)
José Medina-Echeverz, Maria Hinterberger, Marco Testori, Marlene Geiger, Raphael Giessel, Barbara Bathke, Ronny Kassub, Fabienne Gräbnitz, Giovanna Fiore, Sonia T Wennier, Paul Chaplin, Mark Suter, Hubertus Hochrein, Henning Lauterbach
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies. Nature communications 10 (1) (2019)
Barbara Bathke, Juliane Pätzold, Ronny Kassub, Raphael Giessel, Kerstin Lämmermann, Maria Hinterberger, Kay Brinkmann, Paul Chaplin, Mark Suter, Hubertus Hochrein, Henning Lauterbach
CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice. Immunology 154 (2) (2018)

Henning Lauterbach.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Henning Lauterbach